Paula
Rodríguez Otero
Consultora Médica
Tel Aviv University
Tel Aviv, IsraelTel Aviv University-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2023
-
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents
Blood, Vol. 141, Núm. 3, pp. 219-230
2021
-
Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study
British Journal of Haematology, Vol. 192, Núm. 5, pp. 869-878
2016
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557